University of Pilsen   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Pilsen Czech Republic (1991)

Organization Overview

First Clinical Trial
2012
NCT01667536
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

University Hospital of Pilsen, Pilsen, Czech Republic | University Hospital Pilsen | University Hospital Plzen, Department of Urology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 4)

Hypertension (Phase 4)

Lipid Metabolism Disorders (Phase 4)

Metabolic Diseases (Phase 4)

Prostatic Neoplasms (Phase 2)

Respiratory Insufficiency (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8